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 Abstract 
Objectives: To assess the prevalence of cryptic silver (Ag+) resistance amongst clinical isolates 
of Gram-negative bacteria, and to examine how overt Ag+ resistance becomes activated in 
such strains.   
Methods: Established methods were used to determine the susceptibility of 444 recent 
clinical isolates to Ag+, and to evaluate the potential for overt Ag+ resistance to emerge from 
these isolates by spontaneous mutation. The genetic basis for Ag+ resistance was investigated 
using PCR amplification and DNA sequencing. 
Results: None of the isolates tested displayed overt Ag+ resistance. However, upon silver 
challenge, high-level Ag+ resistance (silver nitrate MIC >128 mg/L) was selected at high 
frequency (10-7 to 10-8) in ~76% isolates of Enterobacter spp., ~58% isolates of Klebsiella spp., 
and ~0.7% isolates of E. coli. All strains in which Ag+ resistance could be selected harboured 
the sil operon, with resistance in each case apparently resulting from activation of this system 
as a consequence of a single missense mutation in silS. By contrast, Ag+ resistance could not 
be selected in isolates lacking sil, which included all tested representatives of Acinetobacter 
baumannii, Pseudomonas aeruginosa, Proteus spp and Citrobacter spp. 
Conclusions: Whilst overt Ag+ resistance in Gram-negative pathogens is uncommon, cryptic 
Ag+ resistance pertaining to the sil operon is prevalent and readily activated in particular 
genera (Enterobacter and Klebsiella).  
Introduction  
The silver cation (Ag+) has a long history of use as an antimicrobial agent, and continues to be 
deployed extensively in the healthcare setting for the prevention and treatment of bacterial 
infection. 1, 2 In view of this extensive use, concerns have been raised over the potential for 
Ag+ resistance to emerge in bacteria of clinical relevance and to thereby compromise its 
therapeutic utility. 3, 4 Although there is no evidence to date of Ag+ resistance in Gram-positive 
pathogens such as Staphylococcus aureus, 5 several studies have reported a low prevalence 
of Ag+ resistance in Gram-negative pathogens. 6-9 In the latter, resistance to Ag+ results from 
expression of the Sil system, which mediates resistance through a combination of Ag+ 
sequestration in the periplasm (by the SilE protein) and efflux (via the SilCFBA transporter). 4, 
10 Here we report that, whilst resistance to Ag+ is indeed uncommon amongst Gram-negative 
bacteria, a substantial proportion of some Gram-negative species harbour a cryptic sil operon 
that can be activated by mutation to yield overt resistance. 
 
Our decision to investigate the phenomenon of cryptic Ag+ resistance was prompted by 
observations that collectively suggest that the sil operon is not ordinarily expressed in the 
pathogens that harbour it, and that derepression of expression of this system is required for 
overt Ag+ resistance to manifest. In particular, a number of reports have noted the presence 
of genes encoding Sil-system components in Gram-negative species that are nonetheless 
susceptible to Ag+. 4, 9, 11, 12 For example, in a recent study we described individual strains of 
Klebsiella pneumoniae and Enterobacter cloacae that carry the sil operon but do not exhibit 
phenotypic resistance. 4 In these strains, overt resistance could be readily activated via a single 
missense mutation in silS, 4 a gene which encodes a putative sensor kinase that positively 
regulates expression of the sil operon. 10 Furthermore, amongst clinical isolates exhibiting 
overt resistance to Ag+, there is evidence to suggest that resistance is the result of activation 
of a once-cryptic Sil system; expression of the sil operon on the first reported Ag+-resistance 
plasmid (pMG101) was shown to be constitutively high compared with that found on closely-
related plasmids that do not confer Ag+- resistance. 13 
 
To date, there have been no surveys into the prevalence of cryptic Ag+ resistance in clinical 
isolates. Using a recent collection of Gram-negative pathogens isolated from patients from 
the UK and abroad, we confirm here that overt Ag+ resistance is not common amongst this 
group of bacteria. We also establish that cryptic resistance is prevalent in some genera; the 
majority of Enterobacter spp. and Klebsiella spp. tested contained a cryptic Ag+ resistance 
determinant, and these strains were able to evolve high-level Ag+ resistance via a single 
mutational event. 
Materials and Methods  
Bacteria, culture conditions and susceptibility testing  
Bacterial isolates used in this study (n=444; Table 1) were recovered from patients in the UK, 
Ireland and the USA between 2012 and 2015.  Bacteria were routinely cultured at 37oC using 
Mueller Hinton agar (MHA) or broth (MHB). Susceptibility of bacteria to Ag+ (in the form of 
silver nitrate [AgNO3; Sigma Aldrich, Dorset, UK]) was determined by agar dilution using a 
validated method 5 based on the CLSI guidelines for antibacterial drug susceptibility testing. 
14   
 
Selection and characterization of Ag+ resistance  
Selection of spontaneous mutants resistant to Ag+ was carried out essentially as described, 4, 
15 and involved plating saturated cultures (>109 cfu/ml) onto MHA containing 128 mg 
AgNO3/L. The frequency with which mutants resistant to Ag+ arose was determined using 
standard methodology. 15  
Detection of genes encoding the Sil system was achieved by colony PCR using GoTaq® Green 
mastermix (Promega, Southampton UK) and oligonucleotide primers directed at highly 
conserved regions within the sil operon that flank the silS gene (ϱ͛-
AGCGACTCCGCGCTAAAATA and ϱ͛-GGCTTCTGTTTGCTGCATGA [Eurofins Genomics, 
Ebersberg, Germany]). The resultant PCR amplicons were purified using the QiaQuick kit 
(Qiagen, Hilden, Germany) and subjected to DNA sequence determination (GeneWiz, Essex 
UK) using the amplification primers above and two internal sequencing primers (ϱ͛-
CTCCATTACCTCGATGCGCT and ϱ͛-GTTCCTGGCACAGGCAGATA).  
Results and discussion  
From diverse sources, we assembled a collection of 444 clinical isolates comprising the most 
significant Gram-negative genera associated with skin and soft tissue infection (Table 1), and 
tested their susceptibility to Ag+. All isolates were found to be susceptible to 1-8 mg/L AgNO3 
(MIC50 of 4 mg/L, MIC90 of 8 mg/L). These values are similar to those seen for Ag+-susceptible 
laboratory strains of E. coli (MICs of 4-8 mg/L 4) and are substantially lower than those 
observed for known Ag+-resistant strains (MICs of >128 mg/L 4). Consequently, we consider 
all of the isolates in this study to be Ag+ susceptible, and in the absence of clinical breakpoints 
propose an epidemiological cut-off (ECOFF) 16 of A?8 mg/L, when using the susceptibility 
testing methodology employed here, to distinguish Gram-negative strains whose response to 
Ag+ ŝƐ ?ǁŝůĚ-ƚǇƉĞ ?ĨƌŽŵƚŚŽƐĞƚŚĂƚĞǆƉƌĞƐƐĂŶŐ+ resistance mechanism. Our data corroborate 
previous reports that overt Ag+ resistance is rare amongst Gram-negative pathogens. 6, 9  
To detect cryptic Ag+ resistance, we screened all 444 isolates for their ability to yield resistant 
colonies upon Ag+ challenge. Plating of saturated cultures onto agar containing AgNO3 at 128 
mg/L selected mutants exhibiting Ag+ resistance (MIC >128 mg/L) in ~76% isolates of 
Enterobacter spp., ~58% isolates of Klebsiella spp., and ~0.7% isolates of E. coli (Table 1). The 
frequency with which Ag+-resistant mutants arose was subsequently measured in a subset of 
these strains (n=60). Mutation frequencies to Ag+ resistance in all 60 isolates were similar 
(ranging from ~1.5 x 10-8 to ~5.2 x 10-7), and sufficiently high to imply that resistance was the 
result of a single mutational event in each case. By contrast, resistance to Ag+ could not be 
selected under these conditions in any of the other genera tested (Table 1).  
To determine the genetic basis for Ag+ resistance in the mutants recovered, we proceeded on 
the basis that the Ag+ resistance phenotype in these strains was likely the result of mutational 
activation of a cryptic Sil system, and screened for the presence of the sil operon using PCR 
to detect silS. In all 119 isolates in which spontaneous resistance to Ag+ could be selected, silS 
was detected; by contrast, silS was not found in a cross-section of isolates (n=30) from which 
Ag+ resistant mutants were not recovered. DNA sequence determination of the entire silS 
gene from all 119 silS+ isolates, and from a single Ag+ resistant mutant recovered from each 
isolate, revealed a single missense mutation in each resistant mutant by comparison with the 
Ag+-sensitive parental strain (data not shown). Consequently, it appears that Ag+ resistance 
in all mutants selected is attributable to activation of the Sil system as a result of mutational 
change in silS. 
The SilS protein is the sensor histidine kinase (SHK) of a two-component regulatory system 
that acts to positively regulate the sil operon via phosphorylation of the transcription factor, 
SilR. 17 Though SilS is itself not well studied, SHK proteins as a class have been extensively 
investigated, offering the opportunity to understand mutational gain of function in the SilS 
protein by analogy. We employed Pfam 18 searches to predict the location and extent in SilS 
of functional domains that are common to SHK proteins, and used this information to produce 
a schematic of SilS onto which all of the substitutions identified in this study were mapped 
(Figure 1). This analysis revealed that the substitutions leading to activation of SilS are 
clustered within three functionally-distinct regions; the transmembrane domains, the 
dimerization/histidine phosphotransfer (Dhp) domain and the catalytic/ATP-binding (CA) 
domain (Figure 1).  Substitutions identified in the latter two domains are located at similar 
positions to those found in mutants of the SHKs EnvZ and PhoB that exhibit constitutive 
activation as a consequence of being unable to dephosphorylate their cognate response 
regulator, 19 suggesting that this is also the case for these mutant SilS proteins. By contrast, 
the substitutions found in the transmembrane regions adjacent to the sensory domain may 
prompt constitutive activation of the Sil system by uncoupling signalling from sensing. 20 
In summary, within a large collection of recent Gram-negative clinical isolates, no overt 
resistance to Ag+ was detected. Nevertheless, amongst Klebsiella and Enterobacter spp., high-
level (MIC >128 mg/L) Ag+ resistance was readily selected in the majority of isolates, with 
resistance arising in all cases apparently as a consequence of a single mutation in silS that led 
to activation of the Sil system. The high frequencies (c. 10-8) with which Ag+ resistance arose 
in these isolates is comparable to that seen for antibiotics that act upon a single cellular 
target, agents that are generally considered unsuitable for monotherapy owing to resistance 
liabilities and the consequent likelihood that resistance will arise during treatment. 21   Thus, 
we consider that cryptic resistance has the potential to compromise the efficacy of Ag+-based 
therapeutics, and suggest that it would be of benefit for clinicians to screen patients for the 
presence of strains harbouring cryptic Ag+ resistance determinants prior to deployment of 
such agents. We recommend the use of the simple screening approach for cryptic Ag+ 
resistance that we have employed here, involving the plating of saturated cultures of isolates 
onto agar containing suprainhibitory concentrations of Ag+, and noting the growth of resistant 
colonies following overnight incubation. 
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Table 1. Prevalence of cryptic Ag+ resistance amongst the isolates analysed in this study. 
Isolate type Number of 
isolates 
tested 
Number of isolates in 
which Ag+ resistance 
could be selected (%) 
Acinetobacter spp. 27 0 
Citrobacter spp. 5 0 
Enterobacter spp. 75 57 (76%) 
Escherichia coli 135 1 (0.7%) 
Klebsiella spp. 105 61 (58%) 
Proteus spp. 6 0 
Pseudomonas aeruginosa 91 0 
 
 
 
Figure 1. Schematic of the SilS protein showing the predicted domain architecture by 
comparison with other sensor histidine kinase proteins, and indicating the sites of amino 
acid substitutions that activate the cryptic Sil system. The amino acid substitutions shown 
were all detected in single mutants, with the exception of A13V and G210E that were found in 
mutants selected from two and three independent isolates, respectively. TM: transmembrane 
domain; HAMP: histidine kinase/adenylyl cyclase/methyl-accepting/phosphatase domain; 
DHp: dimerization and histidine phosphotransfer; CA:  catalytic and ATP-binding domain.   
 
 
